FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S. health agencies.
Watch CBS News
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S. health agencies.
Tony's Chocolonely is recalling some products after consumers reported finding "small stones" in the chocolate bars.
Some Egg Beaters and Bob Evans egg products have been recalled because they may include a cleaning solution, USDA says.
Disability rights advocates say income and asset caps for Medicaid buy-in programs are a "poverty trap" for millions of Americans.
A lot of smokers are switching to e-cigarettes to try and kick their nicotine fix, but does vaping really help kick the habit?
Nestlé USA cites consumer complaints, including "one potential choking incident" for recalling products sold nationwide.
Tuolumne County Public Health officials on Tuesday warned about possible measles exposure at a high school and an emergency room.
Most cases have been from an outbreak in Texas and New Mexico, the CDC says.
Dr. Mehmet Oz, the former surgeon and television host, was nominated to head the Centers for Medicare and Medicaid Services.
James Harrison, an Australian man credited with saving 2.4 million babies through his record-breaking blood plasma donations over six decades, has died, his family says. He was 88.
Experts in Sacramento are seeing a rise in a little-known eating disorder that primarily affects adolescents. It's called ARFID and can often be mistaken for just being a picky eater.
Breakfast chain cites supply shortages and surging prices in its tacking on of temporary extra fee for meals with eggs.
Research is just beginning on the impacts that the Palisades and Eaton wildfires in Southern California had on the health of first responders.
Recalled supplemental shakes were distributed to hospitals and long-term care facilities nationwide, federal officials say.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
